|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, June 04, 2024 ) As per Maximize Market research, the Minimal Residual Disease Testing Market was valued at USD 1.60 Bn in 2023 and is expected to reach USD 410.62 Bn by 2030, at a CAGR of 12.8 % during the forecast period.
Minimal Residual Disease Testing Market Report Scope and Research Methodology
The report provides an in-depth analysis of the Minimal Residual Disease Testing Market, covering market dynamics, key players, and regional insights. The research methodology involves primary and secondary data sources, including industry expert interviews, company reports, and database analysis.
Request For Free Sample Report : https://www.maximizemarketresearch.com/request-sample/234192
Minimal Residual Disease Testing Market Dynamics:
The Minimal Residual Disease Testing Market is driven by the rising prevalence of cancer, increasing adoption of personalized medicine, and growing demand for effective disease monitoring. However, factors like high test costs, lack of awareness, and regulatory hurdles may hamper market growth.
Minimal Residual Disease Testing Market Regional Analysis
The North American region is leading the global Minimal Residual Disease Testing Market, attributed to the presence of major market players, well-established healthcare infrastructure, and favorable reimbursement policies. The region's advanced research capabilities, coupled with increasing investments in cancer research, contribute significantly to market growth.
Request For Free Sample Report : https://www.maximizemarketresearch.com/request-sample/234192
Minimal Residual Disease Testing Market Segmentation
by Technology
Flow Cytometry
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Others
by Application
Hematological Malignancy
Lymphoma
Leukaemia
Solid Tumors
Others
by End User
Hospitals and Specialty Clinics
Diagnostic Laboratories
Academic and Research Institutes
Others
Request For Free Sample Report : https://www.maximizemarketresearch.com/request-sample/234192
Minimal Residual Disease Testing Market Key Players Includes
Exact Sciences Corporation
GRAIL, LLC
Veracyte, Inc.
Natera, Inc.
Guardant Health
FOUNDATION MEDICINE, INC.
Inc
Maximize Market Research is leading Healthcare research firm, has also published the following reports:
Minimally Invasive, Non-Invasive Device Market – The market size was USD 48.50 Billion in 2022, and it is estimated to grow at a CAGR of 13.4% from 2023 to 2029.
Surgical Rasps Market - The market size was valued at USD 498.2 Mn in 2023 and Surgical Rasps Market revenue is expected to reach USD 569.6 Mn by 2030, at a CAGR of 4.4 % over the forecast period.
About Maximize Market Research
Maximize Market Research provides B2B and B2C research on 6,500 high-growth emerging opportunities and technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics and communications, Internet of Things, Food and Beverages, Aerospace and defense, and other manufacturing sectors.
MAXIMIZE MARKET RESEARCH PVT. LTD.
L Godage
09607365656
akash.r@maximizemarketresearch.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
